🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Julie E. Lang

University of Kentucky

ORCID: 0000-0002-7534-6124

Also affiliated with University of Alaska Anchorage, Cleveland Clinic Lerner College of Medicine, Saint Joseph Hospital, Alaska Neurology Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

Nature Communications(2021)10.1038/s41467-021-26019-y

N/A

0DataRank · unranked

73 citations

Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, L. J. van ‘t Veer, Douglas Yee +46 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

Association of surgery and radiotherapy with risk of thoracic soft tissue sarcoma among older survivors of breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e24063

N/A

0DataRank · unranked

0 citations

Gretchen L. Gierach, Lene H.S. Veiga, Kaitlyn Hardell, Julie E. Lang, Sujata Patil +4 more

Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer

Cancer Discovery(2025)10.1158/2159-8290.cd-23-0543

N/A

0DataRank · unranked

5 citations

Anna Reva, David G. Edwards, Bree M. Lege, Laura Muñoz-Arcos, Carolina Reduzzi +22 more

Mechanical Conditioning (MeCo) Score Progressively Increases Through the Metastatic Cascade in Breast Cancer via Circulating Tumor Cells

Cancers(2025)10.3390/cancers17101632

N/A

0DataRank · unranked

2 citations

Casey Connors, Adam Watson, Adam Grant, Daniel Campo, Alexander Ring +3 more

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The Lancet Oncology(2021)10.1016/s1470-2045(21)00589-1

N/A

0DataRank · unranked

447 citations

Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze +94 more